NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
NanoViricides, a development stage company, has reported effectiveness of an anti-influenza drug candidate, under FluCide program, when given orally. According to the information received from the contract laboratory that performed the ...